SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare submits analyst meet intimation

14 May 2026 Evaluate
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shilpa Medicare has enclosed the schedule of Q4- FY26 Earnings Conference Call, which is to be held on Friday, May 22, 2025, at 16.00 hrs. A copy of this intimation is also being made available at: https://www.vbshilpa.com/investor-presentation.php

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

546.20 7.30 (1.35%)
12-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.25
Dr. Reddys Lab 1273.90
Cipla 1388.80
Zydus Lifesciences 1104.35
Lupin 2292.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: